Gilead Sciences to Present at Two Upcoming Investor Conferences

Gilead Sciences, Inc. (Nasdaq:GILD)

-- Thomas Weisel Partners Healthcare Tailwinds 2006 Conference on
September 6th

-- BioCentury Newsmakers in the Biotech Industry Conference on
September 7th

-- Webcasts Available Through Gilead Corporate Website

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it will
be webcasting at two upcoming investor conferences: the Thomas Weisel
Partners Healthcare Tailwinds 2006 Conference, in Boston,
Massachusetts, and the BioCentury Newsmakers in the Biotech Industry
Conference in New York, New York. These webcasts may be accessed via
the company's corporate website at www.gilead.com.
John Martin, Ph.D., Gilead's President and Chief Executive
Officer, will provide an overview of the company and an update on key
business milestones at the Thomas Weisel Partners conference on
Wednesday, September 6th at 10:20 a.m. Eastern Time and at the
BioCentury conference on Thursday, September 7th at 2:30 p.m. Eastern
Time.
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company's website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of unmet
medical need. The company's mission is to advance the care of patients
suffering from life-threatening diseases worldwide. Headquartered in
Foster City, California, Gilead has operations in North America,
Europe and Australia.

For more information on Gilead Sciences, please visit
www.gilead.com or call the Gilead Public Affairs Department at
1-800-GILEAD-5 (1-800-445-3235).